Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
10.4 %
$ 147 M
Market Cap
-0.68
P/E
IKT - OPERATING EXPENSES
Operating Expenses IKT - Inhibikase Therapeutics, Inc.
6.73 M
LAST VALUE
-32.48%
2 YEAR CAGR
25.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR